Pharmaids Pharmaceuticals

69.99
-0.26
(-0.37%)
Market Cap
246.88 Cr
EPS
-3.56
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
87.46
52 Week low
31.90
PB Ratio
3.69
Debt to Equity
0.09
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
15.99 %
Net Income Growth
55.26 %
Cash Flow Change
-164.18 %
ROE
-50.06 %
ROCE
-60.05 %
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
0
0
0
0
0
0
-0
1
6
5
5
5
Expenses
0
1
1
9
2
2
1
3
11
8
8
8
EBITDA
-0
-1
-1
-9
-1
-1
-1
-2
-6
-4
-3
-3
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
-12,200 %
-96 %
-75 %
-50 %
-62 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
Interest
0
0
0
0
0
0
0
0
1
0
0
1
Profit Before Tax
-0
-1
-1
-9
-1
-1
-1
-2
-7
-4
-4
-4
Tax
0
0
0
-2
0
0
-1
-1
-1
-1
-1
-1
Net Profit
-0
-1
-1
-6
-1
-1
-1
-1
-6
-3
-3
-3
EPS in ₹
0.00
-0.05
-0.54
-4.76
-0.61
-0.61
-0.24
-0.54
-2.82
-0.76
-0.73
-0.55

Balance Sheet

Balance Sheet
2022
2023
2024
Total Assets
11
25
91
Fixed Assets
0
0
63
Current Assets
3
18
14
Capital Work in Progress
0
2
7
Investments
0
3
0
Other Assets
11
19
21
Total Liabilities
11
25
91
Current Liabilities
2
2
12
Non Current Liabilities
0
0
9
Total Equity
9
23
71
Reserve & Surplus
-2
1
37
Share Capital
10
21
35

Cash Flow

Cash Flow
2022
2023
2024
Net Cash Flow
0
12
-8
Investing Activities
1
-5
-75
Operating Activities
-0
-4
-11
Financing Activities
0
21
78

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Apr 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
65.81 %
65.80 %
65.65 %
55.56 %
35.44 %
20.70 %
21.08 %
16.54 %
16.45 %
9.95 %
9.94 %
9.70 %
9.25 %
5.64 %
5.64 %
5.56 %
5.19 %
5.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.44 %
33.19 %
33.70 %
43.47 %
63.98 %
78.72 %
74.07 %
69.78 %
69.87 %
81.71 %
81.27 %
81.93 %
60.78 %
41.06 %
41.06 %
41.14 %
41.03 %
36.42 %
Others
0.74 %
1.01 %
0.65 %
0.97 %
0.58 %
0.57 %
4.84 %
13.68 %
13.68 %
8.34 %
8.79 %
8.37 %
29.96 %
53.30 %
53.30 %
53.29 %
53.78 %
58.37 %
No of Share Holders
5,861
7,192
7,331
8,314
9,620
9,495
9,193
8,862
8,196
7,761
7,476
7,393
7,281
7,554
7,567
7,594
8,050
8,349

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 20, 2025, 13:45
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 19, 2025, 17:58
Announcement Under Regulation 30 (LODR)- Intimation On Loan Agreement
Feb 13, 2025, 17:48
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 13, 2025, 10:57
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Feb 12, 2025, 17:51
Announcement under Regulation 30 (LODR)-Change in Management
Feb 12, 2025, 17:47
Integrated Filing (Financial)
Feb 12, 2025, 17:09
Financial Results For The Quarter And Nine Months Ended December 31 2024
Feb 12, 2025, 16:53
Board Meeting Outcome for For Declaration Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024
Feb 12, 2025, 16:52
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024.
Feb 07, 2025, 18:05
Outcome Of The Circular Resolution Passed By The Board Of Directors Of The Company On February 06 2025
Feb 06, 2025, 18:43
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Feb 05, 2025, 17:30
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Jan 10, 2025, 17:28
Draft Letter of Offer
Jan 10, 2025, 17:02
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 06, 2025, 17:22
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Jan 03, 2025, 16:36
Detailed Public Statement
Jan 03, 2025, 16:10
Announcement Under Regulation 30 - Intimation For Execution Of Share Purchase Agreement
Dec 27, 2024, 17:18
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
Dec 27, 2024, 17:07
Public Announcement - Open Offer
Dec 27, 2024, 16:55
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
Dec 23, 2024, 17:26
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 17, 2024, 14:25
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 16, 2024, 12:48
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 12, 2024, 17:51
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 11, 2024, 14:09
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 09, 2024, 18:31
Intimation Of Receipt Of National GLP Certification For Material Subsidiary Of The Company.
Dec 09, 2024, 18:13
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 06, 2024, 14:27
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 05, 2024, 14:11
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 03, 2024, 18:08
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Dec 02, 2024, 17:52
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
Nov 28, 2024, 14:49
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 14, 2024, 14:21
Announcement Under Regulation 30 - Contact Details Of KMP For Determining Materiality Of Event/ Information And Making Disclosure.
Nov 13, 2024, 15:29
Financial Results For The Quarter And Half Year Ended September 30, 2024
Nov 13, 2024, 15:08
Board Meeting Outcome for Board Meeting Outcome For Declaration Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.
Nov 13, 2024, 15:05
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.
Nov 09, 2024, 14:47
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024.
Nov 07, 2024, 15:19
Announcement Under Regulation 30 Of SEBI (LODR) Regulation 2015 - Clarification On Price Movement.
Nov 04, 2024, 13:11
Clarification sought from Pharmaids Pharmaceuticals Ltd
Nov 04, 2024, 12:17
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.
Oct 30, 2024, 18:08
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Oct 30, 2024, 16:25
Announcement Under Regulation 30 (LODR) - Intimation On Loan Agreement.
Oct 22, 2024, 18:24
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 10, 2024, 11:06
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Oct 09, 2024, 18:04
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 27, 2024, 13:31
Closure of Trading Window
Sep 27, 2024, 13:03
Announcement under Regulation 30 (LODR)-Demise
Sep 26, 2024, 17:21
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 26, 2024, 17:17
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 25, 2024, 16:25

Technical Indicators

RSI(14)
Neutral
52.07
ATR(14)
Volatile
4.27
STOCH(9,6)
Neutral
45.89
STOCH RSI(14)
Neutral
74.80
MACD(12,26)
Bullish
0.44
ADX(14)
Weak Trend
16.25
UO(9)
Bearish
46.87
ROC(12)
Uptrend But Slowing Down
4.26
WillR(14)
Neutral
-36.08